|
|
WikiPedia - 1732 document(s)
1. Cholesterol
2. Cholesterol
3. Hypercholesterolemia
4. High cholesterol
5. Low-density lipoprotein
6. LDL cholesterol
7. Cholesterol embolism
8. High-density lipoprotein
9. HDL cholesterol
10. Cholesterol Depletion
Click here to go to WikiPedia to see additional search results or to modify your search.
|
|
|
|
|
|
|
|
National Guideline Clearinghouse™ - 183 document(s)
1. Diagnosis and treatment of childhood hypercholesterolaemia.
Finnish Medical Society Duodecim - Professional Association.
2004 Jun 14 (revised 2007 Feb 13).
Various pagings.
NGC:005813
2. European guidelines on cardiovascular disease prevention in clinical practice.
European Society of Cardiology (note)- Medical Specialty Society.
2003 Dec (revised 2007).
113 pages.
NGC:006457
3. Treatment of hyperlipidaemia: aims and selection.
Finnish Medical Society Duodecim - Professional Association.
2001 Jan 4 (revised 2007 Feb 9).
Various pagings.
NGC:005830
4. Growth, body composition, and metabolism.
New York State Department of Health - State/Local Government Agency [U.S.].
2004 (revised 2007 Nov).
Various pagings.
NGC:006474
5. Primary prevention of cardiovascular disease in nursing practice: focus on children and youth.
American Heart Association - Professional Association.
2007 June.
15 pages.
NGC:006037
6. VA/DoD clinical practice guideline for the management of dyslipidemia.
Department of Defense - Federal Government Agency [U.S.]
Department of Veterans Affairs (note)- Federal Government Agency [U.S.]
Veterans Health Administration - Federal Government Agency [U.S.].
2001 Dec (revised 2006).
140 pages.
NGC:005303
7. Screening for lipid disorders in adults: U.S. Preventive Services Task Force recommendation statement.
United States Preventive Services Task Force (note)- Independent Expert Panel.
1996 (revised 2008 Jun).
13 pages.
NGC:006542
8. Prevention of secondary disease: lipid screening and cardiovascular risk.
New York State Department of Health - State/Local Government Agency [U.S.].
2007 Jun.
5 pages.
NGC:005743
9. Screening for lipid disorders in children.
United States Preventive Services Task Force (note)- Independent Expert Panel.
2007 Jul 9.
5 pages.
NGC:005678
10. Screening and management of hyperlipidemia.
Michigan Quality Improvement Consortium - Professional Association.
2003 Aug (revised 2007 Aug).
1 page.
NGC:005979
11. Screening and management of lipids.
University of Michigan Health System - Academic Institution.
2000 May (revised 2009 Feb).
15 pages.
NGC:007216
12. (1)Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). (2)Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines.
National Cholesterol Education Program - Federal Government Agency [U.S.]
National Heart, Lung, and Blood Institute (U.S.) - Federal Government Agency [U.S.].
1993 Sep (updated 2004) .
Various pagings.
NGC:003746
13. Lipids/fats in pre-dialysis patients.
Caring for Australasians with Renal Impairment - Disease Specific Society.
2005 Dec.
4 pages.
NGC:006104
14. 2007 guidelines for the management of arterial hypertension.
European Society of Cardiology (note)- Medical Specialty Society
European Society of Hypertension - Disease Specific Society.
2003 Jun (revised 2007).
75 pages.
NGC:005732
15. Coronary heart disease (CHD): symptoms, diagnosis and treatment.
Finnish Medical Society Duodecim - Professional Association.
2001 April 30 (revised 2008 Mar 20).
Various pagings.
NGC:006590
16. Early assessment and diagnosis. In: Clinical guidelines for acute stroke management.
National Stroke Foundation (Australia) - Private Nonprofit Organization.
2007 Oct.
5 pages.
NGC:006642
17. Routine prenatal care.
Institute for Clinical Systems Improvement - Private Nonprofit Organization.
1997 Aug (revised 2008 Aug).
89 pages.
[NGC Update Pending]
NGC:006704
18. Metabolic syndrome.
Finnish Medical Society Duodecim - Professional Association.
2004 Jun 29 (revised 2007 Dec 13).
Various pagings.
NGC:005817
19. Preventing cancer, cardiovascular disease, and diabetes. A common agenda for the American Cancer Society, the American Diabetes Association, and the American Heart Association.
American Cancer Society - Disease Specific Society
American Diabetes Association - Professional Association
American Heart Association - Professional Association.
2004 Jun 29.
12 pages.
NGC:003790
20. Lipid screening and cardiovascular health in childhood.
American Academy of Pediatrics (note)- Medical Specialty Society.
2008 Jul.
11 pages.
NGC:006849
Click here to go to National Guideline Clearinghouse™ to see additional search results or to modify your search.
|
|
|
|
PubMed (possible guidelines) - 5140 document(s)
| 7. Similar Antiviral Efficacy and Tolerability Between Efavirenz and Lopinavir/Ritonavir, Administered With Abacavir/Lamivudine (Kivexa), in Antiretroviral-Naïve Patients: A 48-Week, Multicentre, Randomized Study (Lake Study). | Related Articles (PubMed)
| Echeverría P, Negredo E, Carosi G, Gálvez J, Gómez JL, Ocampo A, Portilla J, Prieto A, López JC, Rubio R, Mariño A, Pedrol E, Viladés C, Del Arco A, Moreno A, Bravo I, López-Blazquez R, Pérez-Alvarez N, Clotet B.
Antiviral Res. 2009 Nov 23; [Epub ahead of print]
PMID: 19941906 [PubMed - as supplied by publisher]
|   
Cite this in a wiki/blog
|
| 20. Leisure Time Sedentary Behavior, Occupational/Domestic Physical Activity, and Metabolic Syndrome in U.S. Men and Women. | Related Articles (PubMed)
| Sisson SB, Camhi SM, Church TS, Martin CK, Tudor-Locke C, Bouchard C, Earnest CP, Smith SR, Newton RL, Rankinen T, Katzmarzyk PT.
Metab Syndr Relat Disord. 2009 Nov 9; [Epub ahead of print]
PMID: 19900152 [PubMed - as supplied by publisher]
|
Cite this in a wiki/blog
|
Click here to modify or see additional search results from PubMed (possible guidelines)
|
|
|
|
PubMed Citation Matcher
(good for locating MEDLINE abstracts of articles cited by DARE or Bedside Diagnosis)
1. Association between change in high density lipoprotein cholesterol and cardiovascular disease morbidity and mortality: systematic review and meta-regression analysis. Briel M, Ferreira-Gonzalez I, You J J, Karanicolas P J, Akl E A, Wu P, Blechacz B, Bassler D, Wei X, Sharman A, Whitt I, Alves da Silva S Khalid Z, Nordmann A J, Zhou Q, Walter S D, Vale N, Bhatnagar N, O'Regan C, Mills E J, Bucher H C, Montori V M, Guyatt G H. BMJ. 2009
2. Antiarrhythmic effect of statin therapy and atrial fibrillation: a meta-analysis of randomized controlled trials. Fauchier L, Pierre B, de Labriolle A, Grimard C, Zannad N, Babuty D. Journal of the American College of Cardiology. 2008
3. Effects of statins in patients with chronic kidney disease: meta-analysis and meta-regression of randomised controlled trials. Strippoli G F, Navaneethan S D, Johnson D W, Perkovic V, Pellegrini F, Nicolucci A, Craig J C. BMJ. 2008
4. Primary prevention of cardiovascular mortality and events with statin treatments: a network meta-analysis involving more than 65,000 patients. Mills E J, Rachlis B, Wu P, Devereaux P J, Arora P, Perri D. Journal of the American College of Cardiology. 2008
5. The efficacy and safety of intensive statin therapy: a meta-analysis of randomized trials. Josan K, Majumdar S R, McAlister F A . Canadian Medical Association Journal. 2008
6. Effectiveness of brief structured interventions on risk factor modification for patients with coronary heart disease: a systematic review. Fernandez R, Griffiths R, Everett B, Davidson P, Salamonson Y, Andrew S. International Journal of Evidence-Based Healthcare. 2007
7. Long-term benefit of statin therapy initiated during hospitalization for an acute coronary syndrome: a systematic review of randomized trials. Bavry A A, Mood G R, Kumbhani D J, Borek P P, Askari A T, Bhatt D L. American Journal of Cardiovascular Drugs. 2007
8. Low-density lipoprotein-dependent and -independent effects of cholesterol-lowering therapies on C-reactive protein: a meta-analysis. Kinlay S. Journal of the American College of Cardiology. 2007
9. Meta-analysis of drug-induced adverse events associated with intensive-dose statin therapy. Silva M, Matthews M L, Jarvis C, Nolan N M, Belliveau P, Malloy M, Gandhi P. Clinical Therapeutics. 2007
10. Statins and the risk of colorectal cancer: a meta-analysis of 18 studies involving more than 1.5 million patients. Bonovas S, Filioussi K, Flordellis C S, Sitaras N M. Journal of Clinical Oncology. 2007
11. Statins for the primary prevention of cardiovascular events in older adults: a review of the evidence. Ali R, Alexander K P. American Journal of Geriatric Pharmacotherapy. 2007
12. Systematic review: the safety and efficacy of growth hormone in the healthy elderly. Liu H, Bravata D M, Olkin I, Nayak S, Roberts B, Garber A M, Hoffman A R. Annals of Internal Medicine. 2007
13. The clinical and cost-effectiveness of intensive versus standard lipid lowering with statins in the prevention of cardiovascular events amongst patients with acute coronary syndromes: a systematic review. Greenheld W, Wilson J, Bayliss S, Hyde C. Health Technology Assessment Reports. 2007
14. The management of dyslipidaemias in antiretroviral-treated HIV infection: a systematic review. McGoldrick C, Leen C L. HIV Medicine. 2007
15. Aerobic exercise and lipids and lipoproteins in patients with cardiovascular disease: a meta-analysis of randomized controlled trials. Kelley G A, Kelley K S, Franklin B. Journal of Cardiopulmonary Rehabilitation. 2006
16. Aspirin for the primary prevention of cardiovascular events in women and men: a sex-specific meta-analysis of randomized controlled trials. Berger J S, Roncaglioni M C, Avanzini F, Pangrazzi I, Tognoni G, Brown D L. JAMA. 2006
17. Effects of low-carbohydrate vs low-fat diets on weight loss and cardiovascular risk factors: a meta-analysis of randomized controlled trials. Nordmann A J, Nordmann A, Briel M, Keller U, Yancy W S, Brehm B J, Bucher H C. Archives of Internal Medicine. 2006
18. Effects of oral magnesium supplementation on glycaemic control in type 2 diabetes: a meta-analysis of randomized double-blind controlled trials. Song Y, He K, Levitan E B, Manson J E, Liu S. Diabetic Medicine. 2006
19. Efficacy of lipid lowering drug treatment for diabetic and non-diabetic patients: meta-analysis of randomised controlled trials. Costa J, Borges M, David C, Vaz Carneiro A. BMJ. 2006
20. Fibrates in the prevention of cardiovascular disease in patients with type 2 diabetes mellitus: meta-analysis of randomised controlled trials. Allemann S, Diem P, Egger M, Christ E R, Stettler C. Current Medical Research and Opinion. 2006
Click here to go to DARE (includes Cochrane abstracts) to see additional search results or to modify your search.
|
|
|
|
PubMed (possible systematic reviews) - 1364 document(s)
| 7. Major lipids, apolipoproteins, and risk of vascular disease. | Related Articles (PubMed)
| Emerging Risk Factors Collaboration; Di Angelantonio E, Sarwar N, Perry P, Kaptoge S, Ray KK, Thompson A, Wood AM, Lewington S, Sattar N, Packard CJ, Collins R, Thompson SG, Danesh J.
JAMA (note). 2009 Nov 11;302(18):1993-2000.
PMID: 19903920 [PubMed - in process]
|
Cite this in a wiki/blog
|
| 20. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. | Related Articles (PubMed)
| Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, Fruchart JC, James WP, Loria CM, Smith SC Jr; International Diabetes Federation Task Force on Epidemiology and Prevention; Hational Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; International Association for the Study of Obesity.
Circulation. 2009 Oct 20;120(16):1640-5. Epub 2009 Oct 5.
PMID: 19805654 [PubMed - indexed for MEDLINE]
|
Cite this in a wiki/blog
|
Click here to modify or see additional search results from PubMed (possible systematic reviews)
You found numerous systematic reviews, your may:
- Click here to search PubMed and limit your systematic reviews to the Clinical Evidence, Cochrane and AHRQ.
|
|
|
|
PubMed - 1833 document(s)
| 8. Usefulness of triglycerides-to-high-density lipoprotein cholesterol ratio for predicting the first coronary event in men. | Related Articles (PubMed)
| Cordero A, Andrés E, Ordoñez B, León M, Laclaustra M, Grima A, Luengo E, Moreno J, Bes M, Pascual I, Civeira F, Pocoví M, Alegría E, Casasnovas JA; MEtabolic Syndrome Active Subjects Study Investigators.
Am J Cardiol. 2009 Nov 15;104(10):1393-7.
PMID: 19892056 [PubMed - in process]
|
Cite this in a wiki/blog
|
| 12. Adrenocortical tumor with two distinct elements revealed by combined (18)F-fluorodeoxyglucose positron emission tomography and (131)I nor-cholesterol scintigraphy. | Related Articles (PubMed)
| Libé R, Tissier F, Bienvenu M, Groussin L, Joannidis S, Hignette C, Dousset B, Legmann P, Faraggi M, Richard B, Bertagna X, Tenenbaum F.
J Clin Endocrinol Metab. 2009 Oct;94(10):3631-2. No abstract available.
PMID: 19808858 [PubMed - indexed for MEDLINE]
|
Cite this in a wiki/blog
|
| 18. Design of the DEFINE trial: determining the EFficacy and tolerability of CETP INhibition with AnacEtrapib. | Related Articles (PubMed)
| Cannon CP, Dansky HM, Davidson M, Gotto AM Jr, Brinton EA, Gould AL, Stepanavage M, Liu SX, Shah S, Rubino J, Gibbons P, Hermanowski-Vosatka A, Binkowitz B, Mitchel Y, Barter P; DEFINE investigators.
Am Heart J. 2009 Oct;158(4):513-519.e3.
PMID: 19781408 [PubMed - indexed for MEDLINE]
|
Cite this in a wiki/blog
|
Click here to modify or see additional search results from PubMed - using specific search filter for NOFOCUS limited to last 10 years, limiting to AIM journals, limiting search to title and MeSH Major Topic fields.
|
